Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
一项开放标签、随机、对照的II期研究,旨在评估标准全身治疗联合或不联合立体定向放射治疗对寡转移进展型乳腺癌或非小细胞肺癌患者的疗效(巩固性放射治疗阻断寡转移进展[CURB]):一项研究。
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(23)01857-3
Tsai, Chiaojung Jillian; Yang, Jonathan T; Shaverdian, Narek; Patel, Juber; Shepherd, Annemarie F; Eng, Juliana; Guttmann, David; Yeh, Randy; Gelblum, Daphna Y; Namakydoust, Azadeh; Preeshagul, Isabel; Modi, Shanu; Seidman, Andrew; Traina, Tiffany; Drullinsky, Pamela; Flynn, Jessica; Zhang, Zhigang; Rimner, Andreas; Gillespie, Erin F; Gomez, Daniel R; Lee, Nancy Y; Berger, Michael; Robson, Mark E; Reis-Filho, Jorge S; Riaz, Nadeem; Rudin, Charles M; Powell, Simon N